Half-Year 2022 Financial and Clinical Trials Update slide image

Half-Year 2022 Financial and Clinical Trials Update

HY 2022: Pharmaceuticals Division sales New products compensate for biosimilar erosion CER=Constant Exchange Rates 2022 2021 Change in % CHFM CHFM CHF CER Pharmaceuticals Division 22,347 21,671 3 3 United States 11,363 10,802 5 LO 1 Europe 4,104 4,485 -8 -4 Japan 2,202 1,808 22 34 International 4,678 4,576 2 2 Roche 18
View entire presentation